Albor, Miraluna .

HRN: 01-54-74  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/16/2026
08/23/2026
IV
4.5
Q8
CAP MR; PTB, Lost To Ffup; T/cImmunocompromised State
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: